MIRVETUXIMAB
UNII 4MFH3B1EFU

Substance Identification & Data

This profile provides standardized clinical and technical data for Mirvetuximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4MFH3B1EFU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1453084-36-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4MFH3B1EFU

CAS Registry Number

1453084-36-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MIRVETUXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166766

National Cancer Institute reference terminology for clinical and research data.

INN ID

10187

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

BC-76

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mirvetuximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MIRVETUXIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN FOLATE RECEPTOR .ALPHA.) (HUMAN-MUS MUSCULUS MONOCLONAL M9346A HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL M9346A LIGHT CHAIN, DIMER

MIRVETUXIMAB [INN]

MIRVETUXIMAB [USAN]